FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
about
Physiological and Pharmacological Roles of FGF21 in Cardiovascular DiseasesFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkEndocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyFGF21 and Cardiac PhysiopathologyFibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in PancreasRoles of FGF Signals in Heart Development, Health, and DiseaseFibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic DiseasesInsulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages.Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat CellsCirculating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1α Pathway.Cardiac actions of fibroblast growth factor 23.A Novel CXCR4 antagonist enhances angiogenesis via modifying the ischaemic tissue environment.Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro.From the Cover: Alcohol Inhibition of the Enzymatic Activity of Glyceraldehyde 3-Phosphate Dehydrogenase Impairs Cardiac Glucose Utilization, Contributing to Alcoholic Cardiomyopathy.Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.The role of FGF21 in type 1 diabetes and its complications.Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
P2860
Q26744232-4681C643-3820-4C88-A0D0-88367031AF7EQ26766528-18D14D4C-04A4-4132-ACD4-1A15F95A4B1CQ26781556-3823BF6E-F52C-462D-94E8-F7EFA6387014Q26784524-01C910AB-87CA-48F7-9E61-03A75FA4966AQ27324101-78247996-FFD4-4987-9987-AFC2307C99DDQ28072691-1B79A97E-4B55-49A9-B052-95A8E762B36CQ35794417-CAE87DA6-4F85-4436-8FC7-5FF803477D22Q36107291-C8FEEB50-F403-4205-95D2-23282B88D5E4Q36384125-060CADF1-E857-4B16-A108-C8A02737A0CAQ36512372-77D45394-8568-43EE-B0ED-ECB3DAF40704Q37271698-4A1A36F4-5011-4940-A342-81F301DE224EQ38633258-961D889E-8281-404D-B3CD-D90FEA700474Q38726291-58F1D3F4-5ECE-4092-B9ED-D1957CC652EBQ38977291-273954CB-7656-4463-AFDC-4FD836520D1CQ41911602-D5BEEFB9-CF51-4FC0-9207-76053F889ACFQ47694388-D3527462-3C5E-4537-8F46-AAABC8AE025AQ47724513-1E904F0E-3465-4B21-8D94-92686F3E655AQ52694977-752F9E03-E617-4C97-86FB-794D3174DD89Q55513236-81B8F84D-5B1D-4671-A7EC-7A323F8A24CCQ58699532-4199A391-5CA0-429D-823B-2D1EE4EAA3ED
P2860
FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@ast
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@en
type
label
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@ast
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@en
prefLabel
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@ast
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@en
P2093
P2860
P356
P1476
FGF21 deletion exacerbates dia ...... ng cardiac lipid accumulation.
@en
P2093
Shanshan Zhou
Wenke Feng
Xiaokun Li
Xiaoqing Yan
Zhiguo Zhang
P2860
P304
P356
10.1111/JCMM.12530
P577
2015-03-30T00:00:00Z